Weight-Loss Drug Frenzy Cements Novo Nordisk as Europe’s Most Valuable Company

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Little more than a month since becoming Europe’s most valuable listed company, Novo Nordisk A/S has stretched its lead to almost $90 billion as the buzz around weight-loss drugs gets ever louder.

Israel Latest: IDF Urges Evacuation of Gaza City, Signaling IncursionSt.

James’s Place Says It’s Reviewing Fees; Shares TumbleBlackRock Clients Pull $13 Billion From Long-Term FundsBOE’s Bailey Seeks Ways to Respond Faster When Bank Runs HappenChina’s Credit Growth Beats Expectations on Stronger StimulusIMF Latest: World Bank Says Poorest Need More Funding Than EverUK’s FCA Fines Equifax £11 Million Over Massive Cyber HackNASA Probe Bound for Metal Asteroid to Launch on SpaceX’s Falcon HeavyFrom high flying to burnout, pot industry faces downturn five years...

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 83. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Clothing Stocks Seen as Latest Winners From Weight-Loss DrugsThe boom in weight-loss drugs is set to provide a boost to sportswear brands and clothing retailers, according to Deutsche Bank AG analysts.
출처: BNNBloomberg - 🏆 83. / 50 더 많은 것을 읽으십시오 »